Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

HIGHLIGHTS

• who: Molly Went from the EthicsCollection of patient samples and associated clinico-pathological information was undertaken with written informed consent and relevant ethical review board approval at respective study centres in accordance with the tenets of the Declaration of Helsinki. Specifically for the Myeloma-IX trial by the Medical Research Council (MRC) Leukaemia Data Monitoring and Ethics committee (MREC, ISRCTN68454111), the Myeloma-XI trial by the Oxfordshire Research Ethics Committee (MREC, ISRCTN49407852), HOVON65/ GMMG-, (ISRCTN , have published the Article: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma, in the Journal: NATURE COMMUNICATIONS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.